EmVenio

EmVenio Clinical Research delivers results for you and science for all—bringing trials to real-world patients with access, expertise, and human connection

[EmVenio @EmvenioResearch]

Our team is heading to #SCOPESummit, Feb 2-5 in Orlando! 🌴☀️

Visit us at Booth #1021 to learn how we're bringing clinical trials closer to the community - making research more accessible and efficient for both patients and sponsors.

See you there!

#SCOPE2026

[EmVenio @EmvenioResearch]

Happy Holidays! ✨

As we wrap up an incredible year, we want to express our heartfelt gratitude to our patients, partners, and teams for helping us bring research closer to communities worldwide.

Wishing you a joyful holiday season and a bright year ahead!

[EmVenio @EmvenioResearch]

Broadening reach = better science + faster timelines.

Community-based options open the door for more people to participate in trials - leading to quicker enrollment, stronger data, and more complete research for the future of medicine.

#ClinicalResearch #AccessForAll

[EmVenio @EmvenioResearch]

Meet Dr. Jessica Greb, our newest #PrincipalInvestigator in Detroit, MI!

Dr. Greb is a board-certified pediatrician and internist with deep expertise in sickle cell disease, diabetes, and obesity; She is dedicated to improving health outcomes for patients of all ages.

[EmVenio @EmvenioResearch]

Access changes everything.

When patients can participate in research in their homes and local communities, we open doors to more inclusive, representative studies. Community-based models help sponsors reach more people and achieve better outcomes, faster.

#ReachInResearch

[EmVenio @EmvenioResearch]

It’s #NationalInfluenzaVaccinationWeek!

See how our community-based model reduced dropout and delivered more representative outcomes in a global Phase 3 influenza vaccine trial: https://t.co/Ik8qlcior2

#NIVW #VaccineResearch

[EmVenio @EmvenioResearch]

Today we're giving thanks!

We’re incredibly grateful for the trust of our partners, the dedication of our teams, and the communities that make clinical research possible. Thank you to all the incredible people we work with every day who help turn progress into reality!

[EmVenio @EmvenioResearch]

We’re proud to join communities nationwide in recent Kidney Walk events, supporting the fight against kidney disease. These walks unite people, raise awareness, and fund critical research. See highlights in our latest blog: https://t.co/exCACCHQvv
#KidneyWalk #KidneyHealth

[EmVenio @EmvenioResearch]

Happy Nurse Practitioner Week! 💙

One of our incredible NPs shared: “Witnessing patients find hope is one of the greatest gifts.”

Thank you to all the amazing NPs who lead with compassion and clinical excellence every day!

#NPWeek #NursePractitionerWeek #HealthcareHeroes

[EmVenio @EmvenioResearch]

Oncology trials are growing - but access isn’t keeping up.

Only 6% of new oncology trials in 2024 used decentralized models. With 5,700+ drugs in development and cancer cases rising, the need for scalable, community-based research is critical.

Read more https://t.co/FzVYz6e3hY

[EmVenio @EmvenioResearch]

Our team’s been on the move - sharing insights, learning from peers, and deepening our commitment to community-first research. From Boston to Barcelona to tribal lands, we’re working to expand access and representation in clinical trials. #AccessForAll #EmvenioImpact

[EmVenio @EmvenioResearch]

See you at #DTRA2025!

Our team is heading to Cambridge, Nov 6–7, for DTRA’s Annual Meeting. Connect with Jeff Huntsman, Rachael Sawaya & Ron Ramos to learn how our community-based trial solutions are expanding access and driving meaningful results in research.

#AccessForAll

[EmVenio @EmvenioResearch]

What does it really take to sustain innovation in clinical research?
Jeff Huntsman will join leaders from @pfizer and @Boehringer Ingelheim at #DTRA2025 to unpack it in this expert panel discussion:
🎤 Maintaining Momentum Globally
🗓️ Nov 6 | 1:10 PM

#GlobalImpact #AccessForAll

[EmVenio @EmvenioResearch]

How do we make clinical research truly accessible?

Join Rachael Sawaya at #CNSSummit 2025 for “Putting the Reach in Research: Expanding Access, Accelerating Impact” on November 3rd at 1:05 PM in Cezanne 1 to learn how community-based trials are reshaping global research.

[EmVenio @EmvenioResearch]

We're heading to #CNSSummit 2025!

Jeff Huntsman & Rachael Sawaya will be in Boston Nov 2–5 to explore what’s next in clinical research. Let’s connect to talk about how EmVenio is expanding access through community-based trials—driving better outcomes for all. #EmVenioImpact

[EmVenio @EmvenioResearch]

Attending the Genentech Clinical Trial Innovation Summit?

Join Mark McKenzie,MD, CPI, tomorrow at 11:30 AM for the following session where he’ll share practical insights on building flexible, patient-first site models:

Future Proofing Clinical Sites: Voices from the Frontlines

[EmVenio @EmvenioResearch]

If you're at #SCOPEEU2025, don’t miss Jeff Huntsman’s session on how we're bringing research into communities to expand access, reduce dropout, and deliver more representative data:

- Bringing Research to Every Neighborhood: Expanding Reach to Improve Outcomes
- Oct 14, 4:20pm

[EmVenio @EmvenioResearch]

Excited to join the Clinical Trials in Rural & Tribal Communities Pathways Symposium in Polson, MT, Oct 14–15!

Catch up with us to discuss how we can work together to broaden the reach of clinical trials and ensure rural and tribal communities are fully represented in research!

[EmVenio @EmvenioResearch]

Dr. Srinivas Nalamachu is joining leaders in pain research at Arrowhead’s Pain Therapeutics Summit, Oct 13-14 in San Diego! Advancing science, collaboration, and innovation in pain therapeutics. Excited for what’s ahead!

#PainSummit2025 #ClinicalResearch #PainManagement

[EmVenio @EmvenioResearch]

What happens when clinical trials start with #community first?

Join Jennifer Holloway, DNP, MSN, CRNP at #OCTNewEngland on Oct 15 at 11:30 AM where she will share how outreach, education and trust-building can expand access and improve outcomes in the following speaker session.